within Pharmacolibrary.Drugs.ATC.J;

model J01DF02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00013,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DF02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Carumonam is a monobactam antibiotic formerly developed for the treatment of bacterial infections, particularly those caused by Gram-negative bacteria. It acts by inhibiting bacterial cell wall synthesis. Carumonam is not currently approved or marketed for clinical use.</p><h4>Pharmacokinetics</h4><p>No published detailed human pharmacokinetic parameter data could be identified for carumonam. No clinical PK studies appear available in major literature sources, and all parameter values below are unvalidated estimates based on expected properties of monobactam antibiotics in adults with normal renal function.</p><h4>References</h4><ol><li><p>Horber, F, et al., &amp; Stoeckel, K (1986). Pharmacokinetics of carumonam in patients with renal insufficiency. <i>Antimicrobial agents and chemotherapy</i> 29(1) 116–121. DOI:<a href=&quot;https://doi.org/10.1128/AAC.29.1.116&quot;>10.1128/AAC.29.1.116</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3729324/&quot;>https://pubmed.ncbi.nlm.nih.gov/3729324</a></p></li><li><p>Konishi, K, et al., &amp; Fugono, T (1991). Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis. <i>Antimicrobial agents and chemotherapy</i> 35(6) 1048–1052. DOI:<a href=&quot;https://doi.org/10.1128/AAC.35.6.1048&quot;>10.1128/AAC.35.6.1048</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1929242/&quot;>https://pubmed.ncbi.nlm.nih.gov/1929242</a></p></li><li><p>Bérubé, D, et al., &amp; LeBel, M (1988). Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens. <i>Antimicrobial agents and chemotherapy</i> 32(3) 354–357. DOI:<a href=&quot;https://doi.org/10.1128/AAC.32.3.354&quot;>10.1128/AAC.32.3.354</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3364953/&quot;>https://pubmed.ncbi.nlm.nih.gov/3364953</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DF02;
